Cellectar Biosciences, Inc. (CLRB)
NASDAQ·Healthcare·Biotechnology
$2.44
+1.67%
Mkt Cap $8.78M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$11.00
Range $11.00 – $11.00
Implied Upside
+350.8%
Consensus $11.00 vs current $2.44
NASDAQ·Healthcare·Biotechnology
$2.44
+1.67%
Mkt Cap $8.78M
No recent rating data.
Price Target (2 analysts)
$11.00
Range $11.00 – $11.00
+350.8%
Consensus $11.00 vs current $2.44